| Related Knowledge Base Chapters|
| Journal Articles|
|Daily Cotrimoxazole in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: An observational analysis of the DART cohort|
Walker AS, Ford D, Gilks CF, et al. Lancet. 2010;375:1278-86. Includes commentary from the UCSF Institute for Global Health.
|High rates of survival, immune reconstitution and virologic suppression on second-line antiretroviral therapy in South Africa|
Fox MP, Ive P, Long L. J Acquir Immune Defic Syndr. 2009 Oct 15. Includes commentary from the UCSF Institute for Global Health.
|Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements|
The Antiretroviral Therapy Cohort Collaboration (ART-CC). AIDS. 2009 Oct 23;23(16):2199-208. Includes commentary from the UCSF Institute for Global Health.
|Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring|
The ART-LINC of IeDEA Study Group. AIDS. 2009 Sept10;23(14):1867-1874. Includes commentary from the UCSF Institute for Global Health.
|Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort|
Castelnuovo B, Manabe Y, Kiragga A, et al. Clin Infect Dis. 2009 Sep 15;49(6):965-72. Includes commentary from the UCSF Institute for Global Health.
|Tuberculosis treatment and risk of stavudine substitution in first-line antiretroviral therapy|
Westreich DJ, Sanne I, Maskew M, et al. Clin Infect Dis. 2009 Jun 1;48(11):1617-23.
|Five-year outcomes of initial patients treated in Botswana's National Antiretroviral Treatment Program|
Bussmann H, Wester CW, Ndwapi N, et al. AIDS. 2008;22:2303-11. Includes commentary from the UCSF Institute for Global Health.
|Excessive early mortality in the first year of treatment in HIV type 1-infected patients initiating antiretroviral therapy in resource-limited settings|
Marazzi MC, Liotta G, Germano P, Guidotti G, Altan AD, Ceffa S, et al. AIDS Res Hum Retrovirus. 2008 March 26; Epub. Includes commentary from the UCSF Institute for Global Health.
|Effectiveness of antiretroviral treatment in a South African program: a cohort study|
Fairall LR, Bachmann MO, Louwagie GM, van Vuuren C, Chikobvu P, Steyn D, et al. Arch Intern Med. 2008 Jan 14;168(1):86-93. Includes commentary from the UCSF Institute for Global Health.
|Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa|
Moh R, Danel C, Messou E, Ouassa T, Gabillard D, Anzian A, et al. AIDS. 2007 Nov 30;21(18):2483-91. Includes commentary from the UCSF Institute for Global Health.
|Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia|
Ferradini L, Laureillard D, Prak N, Ngeth C, Fernandez M, Pinoges L et al. AIDS. 2007 Nov 12;21(17):2293-301. Includes commentary from the UCSF Institute for Global Health.
|Implementing antiretroviral therapy in rural communities: the Lusikisiki model of decentralized HIV/AIDS care|
Bedelu M, et al. J Infect Dis. 2007 Dec; 196(Suppl 3):S464-S468. No abstract available. Includes commentary from the UCSF Institute for Global Health.
|The cost effectiveness of antiretroviral treatment strategies in resource-limited settings|
Bishai D, Colchero A, Durack DT. AIDS. 2007 Jun;21(10):1333-40. Includes commentary from the UCSF Institute for Global Health.
|Risk factors for treatment denial and loss to follow-up in an antiretroviral treatment cohort in Kenya|
Karcher H, Omondi A, Odera J, Kunz A, Harms G. Trop Med Int Health. 2007 May;12(5):687-94. Includes commentary from the UCSF Institute for Global Health.
|Discontinuation and modification of highly active antiretroviral therapy in HIV-infected Ugandans: prevalence and associated factors|
Kiguba R, Byakika-Tusiime J, Karamagi C, Ssali F, Mugyenyi P, Katabira E. J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):218-23. Includes commentary from the UCSF Institute
for Global Health.
|Short-Term Risk of AIDS or Death in People Infected with HIV-1 Before Antiretroviral Therapy in South Africa: A Longitudinal Study|
Badri M, Lawn SD, Wood R. Lancet. 2006 Oct 7;368(9543):1254-9. Includes commentary from the UCSF Institute for Global Health.
|Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort|
Calmy A, Pinoges L, Szumilin E, Zachariah R, Ford N, Ferradini L. AIDS. 2006 May 12;20(8):1163-9.
|Modelling the Impact of Antiretroviral Use in Resource-Poor Settings|
Baggaley RF, Garnett GP, Ferguson NM. PLoS Med. 2006 Apr;3(4):e124.
|Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries|
Egger M. Lancet. 2006 Mar 11;367(9513):817-824. (Full text available with free registration.)
|A community-based study of the incidence of trimethoprim-sulfamethoxazole-preventable infections in Malawian adults living with HIV.|
van Oosterhout JJ, Laufer MK, Graham SM, Thumba F, Perez MA, Chimbiya N, Wilson L, Chagomerana M, Molyneux ME, Zijlstra EE, Taylor TE, Plowe CV. J Acquir Immune Defic Syndr.
2005 Aug 15;39(5):626-31.
| Guidelines and Best Practices|
|International ARV Treatment Guidelines|
HIV InSite's collection of international HIV/AIDS treatment guidelines.
|Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants in Resource-Limited Settings: Towards Universal Access, Recommendations for
a Public Health Approach|
World Health Organization, August 7, 2006. [PDF, 2.4MB]
|Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach|
World Health Organization, 2010. [PDF, 1.76MB]
|Antiretroviral Therapy of HIV Infection in Infants and Children in Resource-Limited Settings: Towards Universal Access, Recommendations for a Public Health Approach|
World Health Organization, August 7, 2006. [PDF, 1.6MB]
|Guidelines on Co-trimoxazole Prophylaxis for HIV-Related Infections Among Children, Adolescents and Adults in Resource-Limited Settings: Recommendations for a Public
World Health Organization, August 7, 2006. [PDF, 1.1MB]
|WHO Case Definitions of HIV for Surveillance and Revised Clinical Staging and Immunological Classification of HIV-Related Disease in Adults and Children|
World Health Organization, August 7, 2006. [PDF, 1.1MB]
|Patient Monitoring Guidelines for HIV Care and ART|
World Health Organization, June 19, 2006. [PDF, 3MB]
|Sexual and Reproductive Health of Women Living with HIV/AIDS: Guidelines on Care, Treatment and Support for Women Living with HIV/AIDS and Their Children in
World Health Organization, June 19, 2006. [PDF, 1.6MB]
|Clinical HIV/AIDS Care Guidelines for Resource-Poor Settings|
Médecins Sans Frontières, April 2006. [PDF, 3.7MB]
|Integrated Management of Adolescent & Adult Illness: Interim Guidelines for First Level Facility Health Workers--Acute Care|
WHO, October 2005. [PDF, 2MB] Also in French. Other modules include:
|Standards for Quality HIV Care: A Tool for Quality Assessment, Improvement, and Accreditation|
World Health Organization, November 2004. [PDF, 339K] Also available in French. [PDF,
|HIV/AIDS: A Guide for Nutrition, Care and Support |
Food and Nutrition Technical Assistance Project, Academy for Educational Development, September 2004. [PDF, 780K] See also update, Recommendation for the Nutrient Requirements for People Living with HIV/AIDS,
February 2007. [PDF, 44K]
|Nutrition Counselling, Care and Support for HIV-Infected Women: Guidelines on HIV-Related Care, Treatment and Support for HIV-Infected Women and their Children in
World Health Organization, 2004. [PDF, 3MB]
|Guidance on Ethics and Equitable Access to HIV Treatment and Care|
World Health Organization, 2004. [PDF, 482K]
| Policy Reports, Papers, and Briefs|
|Nutrition Care and Support of People Living with HIV in Countries in Francophone Africa: Progress, Experience, and Lessons Learned|
Djibril Cissé and Serigne M. Diène. Food and Nutrition Technical Assistance II Project, March 2009. [PDF, 204K]
|Prioritizing Second-Line Antiretroviral Drugs for Adults and Adolescents: a Public Health Approach|
Report of a WHO Working Group Meeting. WHO. December, 2007. [PDF, 600 KB]
|Antiretroviral Medication Policy for Refugees|
The United Nations High Commissioner for Refugees (UNHCR), January 2007. [PDF, 196K]
|Delivering Antiretroviral Drugs in Emergencies: Neglected but Feasible -- Consensus Statement|
World Health Organization. November 2006. [PDF, 444K]
|HIV InSite Overview of the President's Emergency Plan for AIDS Relief (PEPFAR)|
Includes core documents, program management tools, and related resources. February 2006.
|Malaria and HIV Interactions and their Implications for Public Health Policy|
World Health Organization, August 2005. [PDF, 313K] Also available in French.
|Combating AIDS in the Developing World |
UN Millennium Project, 2005.
|How Many People Should be on Antiretroviral Therapy for HIV/AIDS?|
Roger England. Institute for Health Sector Development, October 2004. [PDF, 56K]
|Scaling Up Treatment for the Global AIDS Pandemic: Challenges and Opportunities|
Institute of Medicine of the National Academies, July 7, 2004.
|Expanding the Care Continuum For HIV/AIDS: Bringing Carers into Focus|
Jessica Ogden, Simel Esim, Caren Grown. International Center for Research on Women, June 2004. [PDF, 712K]
|An Approach to Rapid Scale-Up Using HIV/AIDS Treatment and Care as an Example|
WHO, 2004. [PDF, 360K]
|Provision of Antiretroviral Therapy in Resource-Limited Settings: A Review of Experience Up To August 2003|
Kathy Attawell, Jackie Mundy. Health Systems Resource Centre, UK Department for International Development, World Health Organisation, November 2003. [PDF, 310K]
|Food and Nutrition Implications of Antiretroviral Therapy in Resource Limited Settings |
Tony Castleman, Eleonore Seumo-Fosso, Bruce Cogill. Food and Nutrition Technical Assistance Project, Academy for Educational Development, August 2003. [PDF, 182K]
|Donation Programmes for HIV/AIDS-Related Drugs: Documenting the Early Experience of the Diflucan Partnership Programme and Viramune Donation Programme|
Sibongile Pefile. The Initiative on Public-Private Partnerships for Health, August 2003. [PDF, 259K]
| Conference Reports and Proceedings|
| Presentations, Interviews, and Roundtable Discussions|
| Research Summaries|
| Provider Education and Training|
|Treatment Issues in Resource-Limited Settings|
This course requires registration and technically expired in 2008. Richard E. Chaisson, Hoosen Coovadia, Mauro Schechter, Clinical Care Options. October 2007.
|Management of the ART Experienced Patient in Resource-limited Settings|
Joel Gallant, Johns Hopkins Center for Clinical Global Health Education, January 11, 2007.
|HIV Rapid Testing - Training Package |
Centers for Disease Control and Prevention, April 2006. The training package was developed to assist countries with equipping individuals with the knowledge and skills
necessary to establish policies and to perform testing in a manner that will assure reporting of test results that are reliable and accurate.
|Follow-Up Care and Treatment for the HIV-Exposed or HIV-Infected Child|
Arthur Ammann, Sahai Burrowes. In: Prevention of Mother-to-Child Transmission of HIV in Resource-Limited Settings: A Training Course. UCSF Center for HIV Information,
|Community Engagement for Antiretroviral Treatment: A Training Manual for Community-Based Organisations, Non-Governmental Organisations and People Living with HIV in
International HIV/AIDS Alliance, December 2005. [PDF, 1.8MB]
|HIV Curriculum for the Health Professional|
Baylor International Pediatric AIDS Initiative, Baylor College of Medicine, January 2010.
|Core Competencies: Results from the International Consensus Meeting on HIV Service Delivery Training and Certification|
WHO, August 2005.
| WHO Basic ART Aid Training Course|
WHO, September 2004.
|Nutrition and HIV/AIDS: A Training Manual |
Regional Centre for Quality of Health Care in Uganda, Food and Nutrition Technical Assistance Project, The LINKAGES Project, August 2003.
|Care of Women Living in Limited Resorce Settings, ReproLearn Tutorial|
ReproLearn, JHPIEGO Corporation, Department of Health and Human Services (DHHS), USAID, 2003.
| Clinician Support Tools|
|HIV Clinical Cases Library|
University of California San Francisco. February 2007.
|HIV/AIDS Image Library|
University of California San Francisco, December 2006.
|HIV/AIDS Clinical Case Studies -- 101 Cases for Training Clinical Staff|
Nazareth Hospital, Kenya, 2006. [PDF, 667K]
|The Columbia Clinical Manual|
Miriam Rabkin, Wafaa El-Sadr, Elaine Abrams. The MTCT-Plus
Initiative, International Center for AIDS Programs, Columbia
University Mailman School of Public Health, 2005. [PDF,
| Program Management Materials|
|Procurement & Supply Management Toolbox|
A central repository for a wide range of health-related procurement supply management tools. The Toolbox facilitates quick selection and access to tools in the public domain. WHO, 2008.
|WHO List of Prequalified Medicinal Products|
A database with information on formulation, origin, and maker for TB, malaria and HIV medications preapproved by the WHO. 2008.
|The PIH Guide to the Community-Based Treatment of HIV in Resource-Poor Settings (2nd Ed.)|
Partners In Health, August 2006. Also available in French.
|Untangling The Web of Price Reductions: A Pricing Guide for the Purchase of ARVs in Developing Countries (15th Edition)|
Médecins Sans Frontières, July 2012. [PDF,795K]
|Price & Quality Reporting (PQR)|
Information on prices and quality of ARVs, anti-TB drugs, antimalarial drugs, and bed
nets. The Global Fund to Fight AIDS, Tuberculosis and Malaria, 2009.
|National AIDS Programmes: A Guide to Indicators for Monitoring and Evaluating National Antiretroviral Programmes|
WHO, 2004. [PDF, 382K]
|Handbook on Access to HIV/AIDS-Related Treatment: A Collection of Information, Tools and Resources for NGOs, CBOs and PLWHA Groups|
UNAIDS, May 20, 2003. [PDF, 2.1MB]
|WHO ARV Toolkit|
Provides user-friendly technical guidance on planning and implementing antiretroviral treatment programs in resource-limited settings for an audience of program managers,
implementers, and their partners in the public and private sectors.
| Patient and Community Education|
|See HIV InSite's Links pages for: |